Understanding SSX4: A Potential Drug Target Or Biomarker (G6759)

Target Name: SSX4

NCBI ID: G6759

SSX4

Understanding SSX4: A Potential Drug Target Or Biomarker

SSX4 (CT5.4) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the transforming growth factor beta (TGF-β) family, which is known for their role in cell growth, differentiation, and repair.

SSX4 has been identified as a potential drug target or biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and subcellular localization have made it an attractive target for small molecule inhibitors.

One of the key challenges in studying SSX4 is its subcellular localization. While it is well established that SSX4 is expressed in the brain, it is not clear where it is located within the cell. This is important, as the brain is a complex and dynamic organ, and targeting SSX4 specifically within this organ is critical for its therapeutic potential.

SSX4 has been shown to play a role in several neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells, and the underlying causes of these diseases are still not fully understood. However, studies have shown that SSX4 is involved in the development and progression of these conditions.

In addition to its involvement in neurodegenerative diseases, SSX4 has also been shown to be involved in cancer. Studies have shown that SSX4 is highly expressed in various types of cancer, including breast, lung, and ovarian cancer. This suggests that targeting SSX4 with small molecule inhibitors may be a promising strategy for the treatment of these cancers.

Another potential application of SSX4 is as a biomarker for certain diseases. The ability to detect and monitor the expression of SSX4 provides a sensitive and reliable method for the diagnosis and prognosis of certain diseases. For example, the expression of SSX4 has been shown to be elevated in individuals with multiple sclerosis, a chronic and progressive disease that affects the central nervous system. This suggests that SSX4 may be a useful biomarker for the diagnosis and progression of this disease.

In conclusion, SSX4 is a protein that has been identified as a potential drug target or biomarker for a variety of diseases. Its subcellular localization and involvement in neurodegenerative diseases, cancer, and autoimmune disorders make it an attractive target for small molecule inhibitors. Further research is needed to fully understand the role of SSX4 in these conditions and to develop effective therapies based on this protein.

Protein Name: SSX Family Member 4

Functions: Could act as a modulator of transcription

The "SSX4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SSX4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets